Schwarzwald Baar Klinikum

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Heart failure2 trials
• Acute myeloid leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Multiple myeloma1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed3 trials

Lead sponsor

• European LeukemiaNet1 trial
• Flinders University1 trial
• GBG Forschungs GmbH1 trial
• IHF GmbH - Institut für Herzinfarktforschung1 trial
• University of Heidelberg Medical Center1 trial
• and 1 more

Running trials

• Active, not recruiting

  Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

  NCT04595565· Phase 3· GBG Forschungs GmbH· Source

• Active, not recruiting

  Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes

  NCT04398654· IHF GmbH - Institut für Herzinfarktforschung· Source

• Active, not recruiting

  2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

  NCT02917720· Phase 2· European LeukemiaNet· Source

Closed trials

• Completed

  Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

  NCT05804032· Phase 3· University of Heidelberg Medical Center· Source

• Completed

  Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

  NCT01918215· Flinders University· Source

• Completed

  Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)

  NCT02013648· Phase 3· University of Ulm· Source